Daniel Skovronsky

Equibles does not estimate personal net worth.

Get an email with a short summary when ELI LILLY & Co publishes a filing, an earnings call transcript or a press release.

Get LLY alerts

About Daniel Skovronsky

The proxy statement of ELI LILLY & Co reports total compensation of $17,786,576 for Daniel Skovronsky in fiscal 2025, including a base salary of $1,490,385. Disclosed compensation is on record for 8 fiscal years. Daniel Skovronsky has spoken on 1 earnings call across 1 company, most recently for ELI LILLY & Co on February 4, 2026. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.

Daniel Skovronsky on recent calls

“Q4 financial performance was also strong as shown on slide 7.”

Other, ELI LILLY & Co Q4 FY2025 Earnings Call · February 4, 2026

Affiliation history

ELI LILLY & Co (LLY)
Source not stated

Current

Company network

ELI LILLY & Co

LLY

Current role

Drug Manufacturers - General · Healthcare

1 appearance Latest appearance 2026-02-04

View calls and events

Leadership on record at ELI LILLY & Co

Juan Luciano CEO
David Ricks Chairman, Board Member
Kimberly Johnson COO
Anat Hakim General Counsel
Carolyn Bertozzi Board Member
Carolyn R. Bertozzi Board Member
Dr. Mary Lynne Hedley Board Member
Jon Moeller Board Member
William Kaelin Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	ELI LILLY & Co (LLY)	M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs	$1,490,385	—	$12,000,000	—	$3,249,039	$159,307	$17,786,576
2024	ELI LILLY & Co (LLY)	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,430,769	—	$7,499,895	—	$3,219,230	$206,980	$12,638,744
2023	ELI LILLY & Co (LLY)	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,330,769	—	$7,483,400	—	$2,408,692	$79,846	$11,853,929
2022	ELI LILLY & Co (LLY)	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,201,923	—	$5,747,500	—	$1,442,308	$72,115	$8,463,846
2021	ELI LILLY & Co (LLY)	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,000,000	$0	$5,024,300	—	$1,100,000	$60,000	$7,527,092
2020	ELI LILLY & Co (LLY)	M.D., Ph.D. Executive Vice President, Chief Scientific and Medical Officer and President, Lilly Research Laboratories	$983,333	$0	$4,456,700	—	$1,102,317	$58,539	$7,352,112
2019	ELI LILLY & Co (LLY)	M.D., Ph.D. Senior Vice President, Chief Scientific and Medical Officer and President, Lilly Research Laboratories	$900,000	$0	$4,074,000	—	$1,188,450	$54,000	$6,662,971
2018	ELI LILLY & Co (LLY)	M.D., Ph.D. Senior Vice President, Chief Scientific Officer, and President, Lilly Research Laboratories	$837,500	$0	$2,806,000	$0	$1,376,431	$50,250	$5,145,898

Recent activity

Earnings call ELI LILLY & Co Q4 FY2025 Earnings Call ELI LILLY & Co (LLY)
2026-02-04